Roche will present new data from its Alzheimer’s development portfolio at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada, from July 27 to 30. These results demonstrate Roche’s all-encompassing approach to treating Alzheimer’s disease at every stage of the patient journey. Key presentations highlight results from the Phase Ib/IIa […]
admin
Akeso’s Ivonescimab Moves Closer to Approval with Third sNDA Acceptance in China
Akeso, Inc. has officially announced that the National Medical Products Administration (NMPA) in China has accepted its supplementary New Drug Application (sNDA) for ivonescimab, a PD-1/VEGF bispecific antibody. The application seeks approval for ivonescimab in combination with chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer (sq-NSCLC). […]
Merck to Showcase Latest HIV Prevention and Treatment Research at IAS 2025
Merck also known as MSD outside the U.S. and Canada, announced that it will present new research data on HIV prevention and treatment at the 13th International AIDS Society Conference on HIV Science (IAS 2025), scheduled for July 13-17, 2025, in Kigali, Rwanda. The business will showcase scientific advancements from […]
CD40/CD40L Inhibitors: Unlocking the Future of Autoimmune and Transplant Therapies
DelveInsight’s comprehensive analysis of the CD40/CD40L inhibitors market delivers a detailed understanding of current treatment trends, the scope of the target population, and an evaluation of the competitive landscape with a forecast extending to 2034. The report places emphasis on indications where CD40/CD40L inhibitors hold potential, including systemic lupus erythematosus […]
Matrix Deepens Commitment to In-Home Care with New Diagnostic Partner
Matrix Medical Network, a recognized leader in delivering high-quality, home-based healthcare services, has announced a strategic partnership with Molecular Testing Labs (MTL), a CLIA- and New York State-certified, CAP-accredited laboratory known for its innovation and excellence in molecular diagnostics. This collaboration marks a significant step forward in Matrix’s ongoing commitment […]
BioLab Investigates Real-World Impact of Amnion Grafts in Chronic Wounds
BioLab Holdings, Inc., a medical manufacturer headquartered in Phoenix and specializing in regenerative medicine and wound healing solutions, has launched a new multicenter hybrid platform trial to assess the clinical effectiveness of its amnion-based wound care products. The trial focuses on treating patients with chronic, hard-to-heal diabetic foot ulcers (DFUs) […]
The Beauty and Wellness Industry Bringing Joy and Confidence
To me, beauty has always been about more than appearances—it’s about how it makes you feel. It’s a way to build confidence, practice self-care, and add a little joy to someone’s day. That belief is what led me to join CVS Health and continues to fuel my passion every day […]
Revolutionizing Melanoma Care: SkylineDx’s CP-GEP Test Minimizes Surgical Risks
SkylineDx, a leading diagnostics innovator specializing in molecular diagnostics for oncology, inflammatory, and infectious diseases, has announced significant findings from a Danish validation study recently published in the Journal of Surgical Oncology. This study confirms that SkylineDx’s Merlin Assay, also known as CP-GEP, can accurately identify cutaneous melanoma patients, particularly […]
Texas Cardiac Arrhythmia Institute First in U.S. to Implant Leadless Heart Failure Therapy Device
The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center electrophysiologists have achieved a significant milestone by being the first medical team in the US to implant a novel, FDA-approved leadless device intended to provide cardiac resynchronization therapy to patients with heart failure. This therapy plays a vital role […]
Saluda Medical Rolls Out EVA Nationwide: A Breakthrough in Spinal Cord Stimulation Treatment
Saluda Medical, Inc., a leader in the advancement of neuromodulation technologies aimed at improving the lives of patients with chronic neurological disorders, has formally declared EVA’s full-scale commercial availability, its most recent advancements in sensing technology, all around the United States. This comes after EVA was approved by the US […]
